Back

Mechanisms of very late stent thrombosis assessed by optical coherence tomographyin japanese patients

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Using optical coherence tomography Stent Thrombosis ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Hiroyoshi Mori

Fujigaoka Hospital, Yokohama (Japan)

5 More presentations in this session

Presentation thumbnail
Optical coherence tomography assessment of dissection following Drug-Coated Balloon treatment in de-novo small vessel disease
Doctor K. Ninomiya (Morioka, JP)
Abstract Slides Video
Presentation thumbnail
Plaque characteristics and slow flow phenomenon during the percutaneous coronary intervention of superficial healed plaques on Optical Coherence Tomography
Associate Professor H. Amano (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
A comprehensive network meta-analysis: comparison of long-term outcomes between intravascular ultrasound, optical coherence tomography, and angiography-guided stent implantation
Doctor T. Akbulut (Kocaeli, TR)
Abstract Slides Video
Presentation thumbnail
Predictors of optical coherence tomography-defined calcified nodules in patients with acute coronary syndrome: a substudy from TACTICS registry
Doctor T. Sugiyama (Tsuchiura, JP)
Abstract Slides Video
Presentation thumbnail
Deep-learning based analysis of intracoronary optical coherence tomography images: detection and characterization of lipid plaques
Mr R. Volleberg (Nijmegen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Using optical coherence tomography
Video

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Markers of coagulation and early coronary stent thrombosis
thumbnail
Congress Presentation
Multiple acute stent thrombosis: desperate times call for desperate measures!
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources